CN1656100A - 带有修饰的内酯环的喜树碱 - Google Patents

带有修饰的内酯环的喜树碱 Download PDF

Info

Publication number
CN1656100A
CN1656100A CNA038125439A CN03812543A CN1656100A CN 1656100 A CN1656100 A CN 1656100A CN A038125439 A CNA038125439 A CN A038125439A CN 03812543 A CN03812543 A CN 03812543A CN 1656100 A CN1656100 A CN 1656100A
Authority
CN
China
Prior art keywords
camptothecine
alkyl
iminomethyl
branched
high camptothecine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA038125439A
Other languages
English (en)
Chinese (zh)
Inventor
M·马尔齐
E·马拉斯托尼
S·彭科
C·皮萨诺
M·O·廷蒂
L·韦希
F·祖尼诺
D·韦尔加尼
W·卡布里
M·阿尔佩贾尼
M·G·帕特里西奥
T·达内利
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Nazionale per lo Studio e la Cura die Tumori
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Istituto Nazionale per lo Studio e la Cura die Tumori
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Nazionale per lo Studio e la Cura die Tumori, Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Istituto Nazionale per lo Studio e la Cura die Tumori
Publication of CN1656100A publication Critical patent/CN1656100A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epoxy Compounds (AREA)
CNA038125439A 2002-05-31 2003-05-28 带有修饰的内酯环的喜树碱 Pending CN1656100A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000305A ITRM20020305A1 (it) 2002-05-31 2002-05-31 Camptotecine con anello lattonico modificato.
ITRM2002A000305 2002-05-31

Publications (1)

Publication Number Publication Date
CN1656100A true CN1656100A (zh) 2005-08-17

Family

ID=11456338

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA038125439A Pending CN1656100A (zh) 2002-05-31 2003-05-28 带有修饰的内酯环的喜树碱

Country Status (22)

Country Link
US (1) US7273873B2 (enExample)
EP (2) EP1511752B3 (enExample)
JP (1) JP4693410B2 (enExample)
KR (1) KR101042042B1 (enExample)
CN (1) CN1656100A (enExample)
AR (1) AR040139A1 (enExample)
AT (2) ATE339422T1 (enExample)
AU (2) AU2003241160B2 (enExample)
BR (2) BR0311329A (enExample)
CA (2) CA2706635A1 (enExample)
CY (2) CY1107311T1 (enExample)
DE (2) DE60308368T3 (enExample)
DK (2) DK1719775T3 (enExample)
ES (2) ES2312090T3 (enExample)
IT (1) ITRM20020305A1 (enExample)
MX (1) MXPA04011682A (enExample)
PE (1) PE20050120A1 (enExample)
PL (1) PL374346A1 (enExample)
PT (2) PT1719775E (enExample)
SI (2) SI1719775T1 (enExample)
TW (1) TWI325866B (enExample)
WO (1) WO2003101995A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102746314A (zh) * 2011-04-18 2012-10-24 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
ITRM20030344A1 (it) 2003-07-14 2005-01-15 Ist Naz Stud Cura Dei Tumori 7-n-poliamminoalchil(ossi)imminometilcamptotecine recanti gruppi protettivi.
HRP20121053T1 (hr) 2007-08-01 2013-01-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Kristalni oblik ii 7-(dimetoksimetil)kamptotecina, njegova upotreba kao međuprodukta, te upotreba produkata dobivenih iz istog
CN104530066A (zh) * 2015-01-06 2015-04-22 华东师范大学 一类新型高喜树碱衍生物、制备方法和用途
EA202092436A1 (ru) 2018-05-14 2021-05-04 Нувейшн Био Инк. Противораковые соединения, нацеливающие на ядерные гормональные рецепторы
CA3138197A1 (en) 2019-05-14 2020-11-19 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
US11952349B2 (en) 2019-11-13 2024-04-09 Nuvation Bio Inc. Anti-cancer nuclear hormone receptor-targeting compounds
IL306010A (en) * 2021-03-23 2023-11-01 Nuvation Bio Inc Anticancer compounds against the nuclear hormone receptor
JP2024516024A (ja) 2021-05-03 2024-04-11 ニューベイション・バイオ・インコーポレイテッド 抗がん核内ホルモン受容体標的化化合物
CA3267963A1 (en) * 2022-09-28 2024-04-04 Nuvation Bio Inc. ANTICANCER COMPOUNDS TARGETING A NUCLEAR HORMONE RECEPTOR

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57116076A (en) * 1981-01-09 1982-07-19 Yakult Honsha Co Ltd Novel camptothecin derivative and its preparation
US4399276A (en) * 1981-01-09 1983-08-16 Kabushiki Kaisha Yakult Honsha 7-Substituted camptothecin derivatives
FR2532591A1 (fr) 1982-09-02 1984-03-09 Hutchinson Nouveau dispositif de securite pour pneumatiques de vehicules ou autres engins
JP3576171B2 (ja) 1995-06-21 2004-10-13 ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーション・シヤンテイフイツク・（エス．セー．エール．アー．エス） カンプトテシンの新規な同族体、その製造方法、その医薬としての用途及びこれを含有する医薬組成物
PT1044977E (pt) * 1999-03-09 2002-09-30 Sigma Tau Ind Farmaceuti Derivados de camptotecina com actividade antitumoral

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102746314A (zh) * 2011-04-18 2012-10-24 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途
CN102746314B (zh) * 2011-04-18 2016-07-06 华东师范大学 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途

Also Published As

Publication number Publication date
AU2003241160A1 (en) 2003-12-19
WO2003101995A2 (en) 2003-12-11
KR20050036909A (ko) 2005-04-20
BR0311333A (pt) 2005-03-15
ATE403659T1 (de) 2008-08-15
DE60308368D1 (de) 2006-10-26
DE60308368T3 (de) 2010-09-16
AU2009236044A8 (en) 2011-07-21
DK1511752T3 (da) 2007-01-29
PT1511752E (pt) 2007-01-31
AR040139A1 (es) 2005-03-16
SI1511752T1 (sl) 2007-02-28
AU2009236044B2 (en) 2011-03-24
EP1719775B1 (en) 2008-08-06
KR101042042B1 (ko) 2011-06-16
CA2706635A1 (en) 2003-12-11
ES2273002T7 (es) 2011-08-01
AU2009236044B8 (en) 2011-07-21
SI1719775T1 (sl) 2009-04-30
EP1511752A2 (en) 2005-03-09
CA2485201C (en) 2010-11-02
TWI325866B (en) 2010-06-11
EP1511752B8 (en) 2007-04-18
WO2003101995A3 (en) 2004-02-19
ITRM20020305A0 (it) 2002-05-31
BR0311329A (pt) 2005-02-22
CY1108793T1 (el) 2014-04-09
PE20050120A1 (es) 2005-03-04
PL374346A1 (en) 2005-10-17
WO2003101995A8 (en) 2004-12-23
US7273873B2 (en) 2007-09-25
AU2003241160B2 (en) 2009-08-20
US20050154003A1 (en) 2005-07-14
JP4693410B2 (ja) 2011-06-01
JP2005531602A (ja) 2005-10-20
ES2312090T3 (es) 2009-02-16
DE60322754D1 (de) 2008-09-18
ITRM20020305A1 (it) 2003-12-01
DK1511752T5 (da) 2010-06-14
DE60308368T2 (de) 2007-09-06
DK1719775T3 (da) 2008-11-17
ES2273002T3 (es) 2007-05-01
ATE339422T1 (de) 2006-10-15
MXPA04011682A (es) 2005-03-31
TW200404806A (en) 2004-04-01
AU2009236044A1 (en) 2009-12-03
CY1107311T1 (el) 2012-11-21
EP1719775A1 (en) 2006-11-08
CA2485201A1 (en) 2003-12-11
PT1719775E (pt) 2008-09-30
EP1511752B3 (en) 2010-03-10
EP1511752B1 (en) 2006-09-13

Similar Documents

Publication Publication Date Title
CN1139592C (zh) 喜树碱衍生物，其制备用途以及中间体
CN1192740A (zh) 新的喜树碱类似物、其制备方法和药物应用及其药物组合物
CN1160402A (zh) 用作pnp抑制剂的嘌呤和鸟嘌呤化合物
CN1656100A (zh) 带有修饰的内酯环的喜树碱
CN1250546C (zh) 四氢吡啶并化合物
CN1168139A (zh) 喜树碱衍生物及其制备方法
CN1064278A (zh) 4-脱氧-4-表鬼臼毒素衍生物或其药学上允许的盐
CN1798744A (zh) 作为nmda/nr2b拮抗剂的3－氟－哌啶化合物
CN1656101A (zh) 喜树碱20位酯
CN1098721A (zh) 稠合的喹啉基二氢吡啶，其制备方法及其药用
CN1100098A (zh) 2-氨基-4-喹啉基-二氢吡啶类化合物及其制备和应用
CN1017901B (zh) 抗精神病药稠环吡啶基哌嗪衍生物的制备方法
CN1266134C (zh) 稠合多环化合物
CN1159806A (zh) 咪唑并吡啶-吡咯烷酮和咪唑并吡啶-噁唑烷酮
CN1301701A (zh) 喜树碱类似物化合物,其制备方法及含有它们的药物组合物
CN1761668A (zh) 具有抗肿瘤活性的喜树碱的7－亚氨基衍生物
CN1050380A (zh) 新的取代烷基哌啶及其作为胆固醇合成抑制剂的应用
HK1079205A (en) Camptothecins with a modified lactone ring
CN1101818C (zh) 20(s)－喜树碱的水溶性C－环类似物,制备方法和用途
CN1345321A (zh) 光学纯的喜树碱类似物
CN1557814A (zh) 高喜树碱类化合物及其制备方法和用途
CN1370175A (zh) 二硫杂环庚烯并(6,5－b)吡啶、和相关组合物与方法
CN1910189A (zh) 含过氧衍生物的双分子,其合成与治疗应用
CN100338071C (zh) 取代的苯并[e][1,4]嗪并[3,2－g]异吲哚衍生物、制备它们的方法和包含它们的药物组合物
CN1122669C (zh) 8H－噻吩并[2，3－b]吡咯嗪－8－酮化合物，其制备方法以及含有它们的药物组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1079205

Country of ref document: HK

C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1079205

Country of ref document: HK